 Aurinia Pharmaceuticals Inc NASDAQ: AUPH has posted topline results from the AURORA 2 continuation study evaluating the long-term safety and tolerability of Lupkynis voclosporin for active lupus nephritis. Lupus is an autoimmune disease. 